In 2023, the highest rates of gonorrhea in the U.S. were reported for the age group between 20 and 24 years, with men having a rate of 691.1 (per 100,000 population) and women a rate of 610.5 (per 100,000 population). This statistic shows the rates of reported cases of gonorrhea in the United States in 2023, by age group and gender.
The highest rate of gonorrhea in the United States, between 1950 and 2023, was reported in 1980 with some 442 cases per every 100,000 population. This statistic shows a timeline of rates gonorrhea rates in the United States for selected years between 1950 and 2023.
In 2023, the highest rates of gonorrhea in the U.S. were reported among the Black population, with men having a rate of ***** per 100,000 population and women a rate of ***** per 100,000 population. This statistic shows the rates of reported cases of gonorrhea in the United States in 2023, by race/ethnicity and gender.
This dataset contains the analysis of surveillance data on Sexually transmitted diseases (STDs) diagnosis for all states in the US. The data was collected from the CDC Division of STD Prevention program from reporting forms and electronic data of the National Electronic Telecommunications System for Surveillance (NETSS). This dataset combines age, sex and races and covers Chlamydia, Gonorrhea and different presentations of Syphilis.
In the United States, the highest number of gonorrhea cases from 1950 to 2023 was reported in 1980 with over a million cases. This statistic shows a timeline of the number of reported cases of gonorrhea in the United States for selected years between 1950 and 2023.
In 2023, Alaska had the highest rate of gonorrhea in the United States with around *** new cases per 100,000 population. This statistic represents the rate of gonorrhea among adults in the United States as of 2023.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Univariable and multivariable linear regression analysis of N. gonorrhoeae infection rates at the county level.
Rates of syphilis in the United States are higher among men than women. This is true for every race and ethnicity, although the difference varies greatly. For example, among the Black population, there were around 62.3 cases of syphilis among men per 100,000 population in 2023 and only 18.8 cases per 100,000 population among women. On the other hand, rates of syphilis among American Indians/Alaska Natives were similarly high for both men and women with rates of 63.6 and 52.9 per 100,000 population, respectively. What is syphilis? Syphilis is a common and treatable sexually transmitted disease (STD). Anyone who is sexually active can contract syphilis, however men who have sex with only men accounted for slightly more cases than other groups in 2022. There are four stages of syphilis, and each stage has different signs and symptoms. The stages are primary, secondary, latent, and tertiary. Syphilis can be cured with antibiotics. How many people get syphilis each year? In 2022, there were around 207,255 cases of syphilis in the United States. This was the highest number of cases recorded since the 1950s. In comparison, in the year 2000, there were only around 31,618 cases. Like chlamydia and gonorrhea, rates of syphilis in the United States have increased over the past couple decades reaching 62 per 100,000 population in 2022. However, this rate is still far below the rate of 146 cases per 100,000 population recorded in 1950. Rates of syphilis in the U.S. are highest among people in their twenties and early thirties.
U.S. Government Workshttps://www.usa.gov/government-works
License information was derived automatically
For current version see: https://data.sandiegocounty.gov/Health/2021-Tuberculosis-and-Sexually-Transmitted-Disease/atni-bxrm
Basic Metadata Gonorrhea Incidence. *Rates per 100,000 population. Age-adjusted rates per 100,000 2000 US standard population.
**Blank Cells: Rates not calculated for fewer than 5 events. Rates not calculated in cases where zip code is unknown.
***API: Asian/Pacific Islander. ***AIAN: American Indian/Alaska Native.
Prepared by: County of San Diego, Health & Human Services Agency, Public Health Services, Community Health Statistics Unit, 2019.
Data Guide, Dictionary, and Codebook: https://www.sandiegocounty.gov/content/dam/sdc/hhsa/programs/phs/CHS/Community%20Profiles/Public%20Health%20Services%20Codebook_Data%20Guide_Metadata_10.2.19.xlsx
NNDSS - TABLE 1HH. Syphilis, Congenital to Syphilis, Primary and Secondary – 2020. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents. Note: This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. Footnotes: U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data. -: No reported cases — The reporting jurisdiction did not submit any cases to CDC. N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction. NN: Not nationally notifiable — This condition was not designated as being nationally notifiable. NP: Nationally notifiable but not published. NC: Not calculated — There is insufficient data available to support the calculation of this statistic. Cum: Cumulative year-to-date counts. Max: Maximum — Maximum case count during the previous 52 weeks. * Case counts for reporting years 2019 and 2020 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
N. gonorrhoeae infection rates by state, 2010–2014.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Project Tycho datasets contain case counts for reported disease conditions for countries around the world. The Project Tycho data curation team extracts these case counts from various reputable sources, typically from national or international health authorities, such as the US Centers for Disease Control or the World Health Organization. These original data sources include both open- and restricted-access sources. For restricted-access sources, the Project Tycho team has obtained permission for redistribution from data contributors. All datasets contain case count data that are identical to counts published in the original source and no counts have been modified in any way by the Project Tycho team. The Project Tycho team has pre-processed datasets by adding new variables, such as standard disease and location identifiers, that improve data interpretabilty. We also formatted the data into a standard data format.
Each Project Tycho dataset contains case counts for a specific condition (e.g. measles) and for a specific country (e.g. The United States). Case counts are reported per time interval. In addition to case counts, datsets include information about these counts (attributes), such as the location, age group, subpopulation, diagnostic certainty, place of aquisition, and the source from which we extracted case counts. One dataset can include many series of case count time intervals, such as "US measles cases as reported by CDC", or "US measles cases reported by WHO", or "US measles cases that originated abroad", etc.
Depending on the intended use of a dataset, we recommend a few data processing steps before analysis:
In 2022, the highest rate of syphilis in U.S. men was reported in the age group between 30 and 34 years, with 62 cases per 100,000 population. This statistic shows the rates of reported cases of primary and secondary syphilis in the United States in 2023, by age group and gender.
In 2023, there were an estimated 1.03 million cases of chlamydia among women in the United States and around 610,445 cases among men. Furthermore, that year, there were around 378,428 cases of gonorrhea among men and 221,176 cases among women. Despite the dangers of sexually transmitted diseases (STDs) being more commonplace and testing and contraception, for the most part, widely accessible in the United States, rates of chlamydia, gonorrhea, and syphilis, have all risen in recent years. Chlamydia in the United States According to the CDC, chlamydia is the most commonly reported bacterial sexually transmitted infection (STI) in the United States. In 2023, there were around 492 cases of chlamydia per 100,000 population, a substantial increase from a rate of 289 per 100,000 population in the year 2002. Those aged 20 to 24 had the highest rates of chlamydia in the U.S. in 2023. Although chlamydia often has no symptoms, it can cause serious health problems if left untreated, one of the reasons those who are sexually active should be regularly tested for STDs. Once diagnosed, chlamydia can be easily cured with antibiotics. Gonorrhea Rates of gonorrhea in the United States decreased after reaching a peak in the 1980s but began to rise again over the past decade. In 2023, there were 179.5 cases of gonorrhea per 100,000 population in the United States, compared to 98 cases per 100,000 population in the year 2009. While rates of chlamydia in the U.S. tend to be higher among women than men, rates of gonorrhea are higher among men, with those aged 20 to 24 the most affected. Like chlamydia, gonorrhea can be cured with medicine but can cause serious and permanent health problems if left untreated.
NNDSS - TABLE 1M. Gonorrhea to Haemophilus influenzae, invasive disease (age <5 years), Serotype b - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents. Note: This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. Footnotes: U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data. -: No reported cases — The reporting jurisdiction did not submit any cases to CDC. N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction. NN: Not nationally notifiable — This condition was not designated as being nationally notifiable. NP: Nationally notifiable but not published — CDC does not have data because of changes in how conditions are categorized. Cum: Cumulative year-to-date counts. Max: Maximum — Maximum case count during the previous 52 weeks. * Case counts for reporting years 2018 and 2019 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the US, a US territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-US Residents' category. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
description: U.S. counties ranked nationally by cases of gonorrhea reported. Data Source: Centers for Disease Control and Prevention 2005-2015 Surveillance Report (http://www.cdc.gov/STD/publications/default.htm); abstract: U.S. counties ranked nationally by cases of gonorrhea reported. Data Source: Centers for Disease Control and Prevention 2005-2015 Surveillance Report (http://www.cdc.gov/STD/publications/default.htm)
NNDSS - TABLE 1M. Gonorrhea to Haemophilus influenzae, invasive disease (age <5 years), Serotype b - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.
Note: This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html.
Footnotes: U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data. -: No reported cases — The reporting jurisdiction did not submit any cases to CDC. N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction. NN: Not nationally notifiable — This condition was not designated as being nationally notifiable. NP: Nationally notifiable but not published — CDC does not have data because of changes in how conditions are categorized. Cum: Cumulative year-to-date counts. Max: Maximum — Maximum case count during the previous 52 weeks. * Case counts for reporting years 2018 and 2019 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the US, a US territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-US Residents' category. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
In 2019, there were 39.68 new cases of syphilis per 100,000 population in the United States. This statistic shows the number of new cases of syphilis per 100,000 population in the United States from 1950 to 2019.
In the United States, the overall rate of syphilis among mothers delivering babies more than tripled from 2016 to 2022, increasing from 87.2 to 280.4 cases per 100,000 births. This statistic depicts the rate of maternal syphilis during pregnancy in the United States from 2016 to 2022, per 100,000 births.
U.S. Government Workshttps://www.usa.gov/government-works
License information was derived automatically
For current version see: https://data.sandiegocounty.gov/Health/2021-Tuberculosis-and-Sexually-Transmitted-Disease/atni-bxrm
Basic Metadata Syphilis Incidence. *Rates per 100,000 population. Age-adjusted rates per 100,000 2000 US standard population.
**Blank Cells: Rates not calculated for fewer than 5 events. Rates not calculated in cases where zip code is unknown.
***API: Asian/Pacific Islander. ***AIAN: American Indian/Alaska Native.
Prepared by: County of San Diego, Health & Human Services Agency, Public Health Services, Community Health Statistics Unit, 2019.
Data Guide, Dictionary, and Codebook: https://www.sandiegocounty.gov/content/dam/sdc/hhsa/programs/phs/CHS/Community%20Profiles/Public%20Health%20Services%20Codebook_Data%20Guide_Metadata_10.2.19.xlsx
In 2023, the highest rates of gonorrhea in the U.S. were reported for the age group between 20 and 24 years, with men having a rate of 691.1 (per 100,000 population) and women a rate of 610.5 (per 100,000 population). This statistic shows the rates of reported cases of gonorrhea in the United States in 2023, by age group and gender.